These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 31451114)

  • 1. A ROS-responsive polymeric prodrug nanosystem with self-amplified drug release for PSMA (-) prostate cancer specific therapy.
    Wang Y; Zhang Y; Ru Z; Song W; Chen L; Ma H; Sun L
    J Nanobiotechnology; 2019 Aug; 17(1):91. PubMed ID: 31451114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pH-Responsive Charge-Reversal Drug Delivery System with Tumor-Specific Drug Release and ROS Generation for Cancer Therapy.
    Xu C; Song R; Lu P; Chen J; Zhou Y; Shen G; Jiang M; Zhang W
    Int J Nanomedicine; 2020; 15():65-80. PubMed ID: 32021165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ROS-Responsive Nanoprobes for Bimodal Imaging-Guided Cancer Targeted Combinatorial Therapy.
    Jiang F; Liu S; Wang L; Chen H; Huang Y; Cao Y; Wang X; Lin M; Zhang J
    Int J Nanomedicine; 2024; 19():8071-8090. PubMed ID: 39130685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEG-PLA nanoparticles decorated with small-molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells.
    Afsharzadeh M; Hashemi M; Babaei M; Abnous K; Ramezani M
    J Cell Physiol; 2020 May; 235(5):4618-4630. PubMed ID: 31674023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSMA-targeted combination brusatol and docetaxel nanotherapeutics for the treatment of prostate cancer.
    Adekiya TA; Hudson T; Bakare O; Ameyaw EE; Adebayo A; Olajubutu O; Adesina SK
    Biomed Pharmacother; 2024 Aug; 177():117125. PubMed ID: 39002444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pH/ROS cascade-responsive and self-accelerating drug release nanosystem for the targeted treatment of multi-drug-resistant colon cancer.
    Chang N; Zhao Y; Ge N; Qian L
    Drug Deliv; 2020 Dec; 27(1):1073-1086. PubMed ID: 32706272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-Specific Membrane Antigen Targeted Therapy of Prostate Cancer Using a DUPA-Paclitaxel Conjugate.
    Lv Q; Yang J; Zhang R; Yang Z; Yang Z; Wang Y; Xu Y; He Z
    Mol Pharm; 2018 May; 15(5):1842-1852. PubMed ID: 29608845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localised delivery of doxorubicin to prostate cancer cells through a PSMA-targeted hyperbranched polymer theranostic.
    Pearce AK; Simpson JD; Fletcher NL; Houston ZH; Fuchs AV; Russell PJ; Whittaker AK; Thurecht KJ
    Biomaterials; 2017 Oct; 141():330-339. PubMed ID: 28711780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ROS-Activated homodimeric podophyllotoxin nanomedicine with self-accelerating drug release for efficient cancer eradication.
    Liang B; Zhou D
    Drug Deliv; 2021 Dec; 28(1):2361-2372. PubMed ID: 34747277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A positive feedback strategy for enhanced chemotherapy based on ROS-triggered self-accelerating drug release nanosystem.
    Hu JJ; Lei Q; Peng MY; Zheng DW; Chen YX; Zhang XZ
    Biomaterials; 2017 Jun; 128():136-146. PubMed ID: 28325685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-responsive doxorubicin-loaded nanomicelles for enhanced cancer therapy.
    Zhang X; Zhu T; Miao Y; Zhou L; Zhang W
    J Nanobiotechnology; 2020 Sep; 18(1):136. PubMed ID: 32972412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dual-amplified ROS-responsive nanosystem with self-accelerating drug release for synergistic chemotherapy.
    Li J; Zong Q; Zhao Z; Yuan Y
    Chem Commun (Camb); 2023 Mar; 59(21):3142-3145. PubMed ID: 36811610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of folate-conjugated liposomes with co-entrapped drugs to prostate cancer cells via prostate-specific membrane antigen (PSMA).
    Patil Y; Shmeeda H; Amitay Y; Ohana P; Kumar S; Gabizon A
    Nanomedicine; 2018 Jun; 14(4):1407-1416. PubMed ID: 29680672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH/ROS dual-responsive supramolecular polypeptide prodrug nanomedicine based on host-guest recognition for cancer therapy.
    Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Chen T; Dong CM; Yao Y
    Acta Biomater; 2022 Apr; 143():381-391. PubMed ID: 35272024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tumor-specific ROS self-supply enhanced cascade-responsive prodrug activation nanosystem for amplified chemotherapy against multidrug-resistant tumors.
    Wang J; Zhang H; Lv J; Zheng Y; Li M; Yang G; Wei X; Li N; Huang H; Li T; Qin X; Li S; Wu C; Zhang W; Liu Y; Yang H
    Acta Biomater; 2023 Jul; 164():522-537. PubMed ID: 37072069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated block copolymer prodrug nanoparticles for combination of tumor oxidative stress amplification and ROS-responsive drug release.
    Yin W; Ke W; Chen W; Xi L; Zhou Q; Mukerabigwi JF; Ge Z
    Biomaterials; 2019 Mar; 195():63-74. PubMed ID: 30612064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PSMA-mediated endosome escape-accelerating polymeric micelles for targeted therapy of prostate cancer and the real time tracing of their intracellular trafficking.
    Gao Y; Li Y; Li Y; Yuan L; Zhou Y; Li J; Zhao L; Zhang C; Li X; Liu Y
    Nanoscale; 2015 Jan; 7(2):597-612. PubMed ID: 25419788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pH/ROS-responsive, tumor-targeted drug delivery system based on carboxymethyl chitin gated hollow mesoporous silica nanoparticles for anti-tumor chemotherapy.
    Ding X; Yu W; Wan Y; Yang M; Hua C; Peng N; Liu Y
    Carbohydr Polym; 2020 Oct; 245():116493. PubMed ID: 32718608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer.
    Yi H; Lu W; Liu F; Zhang G; Xie F; Liu W; Wang L; Zhou W; Cheng Z
    J Nanobiotechnology; 2021 May; 19(1):134. PubMed ID: 33975609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH and ROS sequentially responsive podophyllotoxin prodrug micelles with surface charge-switchable and self-amplification drug release for combating multidrug resistance cancer.
    Li C; Wang Y; Zhang S; Zhang J; Wang F; Sun Y; Huang L; Bian W
    Drug Deliv; 2021 Dec; 28(1):680-691. PubMed ID: 33818237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.